Abstract
Treatment Outcomes of Zanubrutinib-Based Regimen in Newly Diagnosed Patients with MYC/BCL2 Double-Expressor Diffuse Large B-Cell Lymphoma: A Retrospective Multicenter Real-World Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have